C McClinton

1.2k total citations
14 papers, 714 citations indexed

About

C McClinton is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, C McClinton has authored 14 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 4 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in C McClinton's work include Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (4 papers) and Spondyloarthritis Studies and Treatments (3 papers). C McClinton is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (4 papers) and Spondyloarthritis Studies and Treatments (3 papers). C McClinton collaborates with scholars based in United Kingdom, Denmark and Sweden. C McClinton's co-authors include Peter C. Taylor, Ravinder N. Maini, P Marsters, Martin Blomley, Carrie Wagner, James V. Gruber, A Steuer, David O. Cosgrove, P. Charles and Andrew Keat and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and Arthritis Research & Therapy.

In The Last Decade

C McClinton

14 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C McClinton United Kingdom 11 571 209 181 76 62 14 714
Esmeralda T. H. Molenaar Netherlands 11 652 1.1× 235 1.1× 130 0.7× 46 0.6× 109 1.8× 15 775
Melek Güler-Yüksel Netherlands 14 847 1.5× 197 0.9× 136 0.8× 61 0.8× 92 1.5× 19 992
D. van Schaardenburg Netherlands 9 628 1.1× 149 0.7× 178 1.0× 19 0.3× 64 1.0× 34 747
Marie‐Paule Chauveheid France 14 190 0.3× 203 1.0× 148 0.8× 69 0.9× 148 2.4× 33 636
Angelo Zoli Italy 15 275 0.5× 67 0.3× 130 0.7× 95 1.3× 85 1.4× 29 588
Heidi Mäkinen Finland 11 600 1.1× 263 1.3× 74 0.4× 29 0.4× 133 2.1× 19 682
Shabina Sultan United Kingdom 10 441 0.8× 74 0.4× 157 0.9× 64 0.8× 140 2.3× 12 729
Daniel J. Wallace United States 6 725 1.3× 112 0.5× 461 2.5× 25 0.3× 114 1.8× 9 896
Ruth Klaasen Netherlands 9 343 0.6× 89 0.4× 78 0.4× 61 0.8× 60 1.0× 26 509
Emanuele Cassarà Italy 14 494 0.9× 191 0.9× 221 1.2× 33 0.4× 29 0.5× 21 661

Countries citing papers authored by C McClinton

Since Specialization
Citations

This map shows the geographic impact of C McClinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C McClinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C McClinton more than expected).

Fields of papers citing papers by C McClinton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C McClinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C McClinton. The network helps show where C McClinton may publish in the future.

Co-authorship network of co-authors of C McClinton

This figure shows the co-authorship network connecting the top 25 collaborators of C McClinton. A scholar is included among the top collaborators of C McClinton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C McClinton. C McClinton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Aslanis, Vassilios, Robert J. Slack, Alison C. MacKinnon, et al.. (2023). Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer Chemotherapy and Pharmacology. 91(3). 267–280. 25 indexed citations
2.
3.
Pathan, Ejaz, Sonya Abraham, R H Withrington, et al.. (2012). Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. Annals of the Rheumatic Diseases. 72(9). 1475–1480. 98 indexed citations
4.
Pétavy, Frank, Flaminia Chiesa, Pauline T. Lukey, et al.. (2012). Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.. PubMed. 30(2). 254–61. 26 indexed citations
5.
Kelly, Stephen, Chan Beals, Marie‐Pierre Malice, et al.. (2012). Ultrasound of metacarpophalangeal joints is a sensitive and reliable endpoint for drug therapies in rheumatoid arthritis: results of a randomized, two-center placebo-controlled study. Arthritis Research & Therapy. 14(5). R198–R198. 17 indexed citations
6.
Porter, Duncan, K. Gadsby, Paul Thompson, et al.. (2011). DAS28 and Rheumatoid Arthritis: The Need for Standardization. Musculoskeletal Care. 9(4). 222–227. 13 indexed citations
7.
8.
Fisher, Benjamin A., et al.. (2008). Prevalence of subjective voice impairment in rheumatoid arthritis. Clinical Rheumatology. 27(11). 1441–1443. 12 indexed citations
9.
Sokka, Tuulikki, Hannu Kautiainen, S. Toloza, et al.. (2007). QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Annals of the Rheumatic Diseases. 66(11). 1491–1496. 159 indexed citations
10.
Zhang, Zhuoli, Claire Gorman, Claudia Monaco, et al.. (2007). TCRζdimlymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood. 109(10). 4328–4335. 34 indexed citations
11.
12.
13.
Taylor, Peter C., A Steuer, Johann Gruber, et al.. (2003). Ultrasonographic and radiographic evidence of attenuated joint destruction in early RA patients treated with infliximab. Annals of the Rheumatic Diseases. 62. 160–160. 1 indexed citations
14.
Taylor, Peter C., A Steuer, Johann Gruber, et al.. (2002). Infliximab attenuates joint destruction in early RA patients with ultrasonographic markers of poor prognosis.. Oxford University Research Archive (ORA) (University of Oxford). 46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esmeralda T. H. Molenaar Breakdown of academic impact, for papers by Melek Güler-Yüksel Breakdown of academic impact, for papers by D. van Schaardenburg Breakdown of academic impact, for papers by Marie‐Paule Chauveheid Breakdown of academic impact, for papers by Angelo Zoli Breakdown of academic impact, for papers by Heidi Mäkinen Breakdown of academic impact, for papers by Shabina Sultan Breakdown of academic impact, for papers by Daniel J. Wallace Breakdown of academic impact, for papers by Ruth Klaasen Breakdown of academic impact, for papers by Emanuele Cassarà
Rankless by CCL
2026